Introduction 7.5032105
: 2.7003784
Ċ 1.1506985
Mel 14.487671
an 1.7813075
oma 1.6298767
Ġis 0.27702692
Ġan 2.8041017
Ġaggressive 0.8699183
Ġform 1.6801285
Ġof 0.002404856
Ġskin 0.24264832
Ġcancer 0.019539133
Ġthat 1.0224743
Ġcan 1.7468575
Ġmetast 1.9712896
as 0.005216812
ize 0.040843766
Ġrapidly 5.2765346
Ġif 3.2714622
Ġleft 1.0377445
Ġuntreated 0.12320554
. 0.12354479
ĠOver 6.3087378
Ġthe 0.33085406
Ġyears 1.8786108
, 0.5039325
Ġadvancements 5.590039
Ġin 0.2460087
Ġmedical 3.806322
Ġscience 1.3335677
Ġhave 0.45846668
Ġled 1.5196218
Ġto 0.015204663
Ġthe 1.633075
Ġdevelopment 0.5673067
Ġof 0.032901417
Ġgroundbreaking 8.46815
Ġtreatments 1.5467213
, 2.4273963
Ġnotably 6.5326695
Ġimmune 5.901021
Ġcheckpoint 0.83417374
Ġinhibitors 0.29855153
Ġand 3.4676442
Ġadj 6.401427
u 0.14254825
vant 0.00025694142
Ġtherapies 0.9158846
. 0.6710756
ĠThese 2.7040877
Ġnovel 3.2919335
Ġapproaches 3.085688
Ġhave 0.7108417
Ġshown 3.7872064
Ġgreat 2.1052954
Ġpotential 2.6035023
Ġin 0.3517008
Ġachieving 5.426147
Ġlong 1.7587125
- 0.16865811
term 0.17824085
Ġremission 2.9401639
Ġand 1.849769
Ġimproving 1.8565925
Ġsurvival 1.5639341
Ġrates 0.9233529
Ġfor 2.2407131
Ġpatients 0.49150157
Ġat 6.3430004
Ġdifferent 5.387578
Ġstages 0.21256496
Ġof 0.0998836
Ġmelan 1.3565702
oma 0.0021724612
. 0.23149696
ĠThis 3.6840632
Ġessay 5.6059055
Ġaims 2.3430758
Ġto 0.013769488
Ġdiscuss 1.892642
Ġthe 0.4295094
Ġadvancements 4.7427263
Ġin 0.37640902
Ġthese 4.749368
Ġtreatments 1.7607225
, 1.268685
Ġtheir 2.396861
Ġimplications 4.2131534
Ġfor 1.6838819
Ġpatients 2.1696174
, 0.5509577
Ġand 0.17891636
Ġillustrate 8.567537
Ġtheir 2.167089
Ġimpact 3.5434358
Ġon 0.43130648
Ġsurvival 4.057187
Ġrates 0.30879635
Ġthrough 4.054515
Ġthe 1.4667182
Ġcase 2.5714695
Ġof 0.9473405
ĠMr 3.2870705
. 0.36375526
ĠB 3.4099808
. 0.95562416
Ċ 0.3770061
Ad 5.4574947
vance 1.5785817
ments 0.053818904
Ġin 0.058880895
ĠMel 1.5859185
an 4.5374152e-05
oma 0.0001783078
ĠTreatment 0.49905732
: 0.5407495
Ċ 0.0815835
Imm 0.80994284
une 0.050903346
Ġcheckpoint 0.88982236
Ġinhibitors 0.12235063
Ġsuch 3.5049338
Ġas 0.005442064
Ġp 2.4679472
emb 0.0019927954
rol 0.006242631
iz 0.00041327655
um 0.003082635
ab 0.00022075453
Ġand 0.9512461
Ġn 0.11323662
iv 0.00024668477
ol 0.00012203379
um 0.009618214
ab 0.00054029573
Ġhave 0.9745026
Ġrevolution 1.6944153
ized 0.013042163
Ġmelan 1.8818985
oma 0.00058120594
Ġtreatment 0.20197387
. 1.2999004
ĠThese 1.1331868
Ġdrugs 0.8153725
Ġwork 1.4594656
Ġby 0.056240432
Ġblocking 1.6485735
Ġthe 1.0051111
Ġinteraction 1.6910045
Ġbetween 0.2445012
Ġcancer 4.8325768
Ġcells 0.18649836
Ġand 0.024713967
Ġimmune 2.5080943
Ġinhibit 7.4847465
ory 0.0002277888
Ġmolecules 2.6290176
, 1.3111187
Ġthus 1.834385
Ġactivating 4.0687532
Ġthe 0.2327352
Ġimmune 0.52862084
Ġsystem 0.07860115
Ġto 0.6736757
Ġrecognize 2.1846137
Ġand 0.25335985
Ġeliminate 2.553849
Ġcancer 0.87815124
Ġcells 0.2456437
. 0.16718733
ĠThey 3.5250137
Ġhave 0.49714464
Ġdemonstrated 2.727287
Ġremarkable 2.4127512
Ġsuccess 2.1214986
Ġin 0.2869012
Ġachieving 2.0518458
Ġdurable 3.2804353
Ġresponses 1.1143814
Ġand 1.3982404
Ġprolonged 3.8022432
Ġsurvival 0.3211488
Ġrates 2.007162
Ġin 0.9731092
Ġmetast 3.608798
atic 0.0022253871
Ġmelan 0.12728168
oma 0.0064613326
Ġpatients 0.35794395
. 0.4457952
Ċ 1.547245
Additionally 6.8894453
, 0.003493708
Ġadj 1.518286
u 0.01694904
vant 3.237946e-05
Ġtherapies 0.49808678
, 2.6595414
Ġsuch 0.838254
Ġas 0.001152894
Ġinter 3.2381728
fer 0.26146695
on 0.048921842
Ġtherapy 3.9456506
, 0.5930579
Ġtargeted 5.5744205
Ġtherapy 0.9952375
, 0.50902385
Ġand 0.30915263
Ġcancer 5.654251
Ġvaccines 0.12797715
, 0.47803783
Ġhave 0.3697991
Ġplayed 4.90567
Ġa 0.52972275
Ġpivotal 2.2560103
Ġrole 0.008881154
Ġin 0.009770002
Ġreducing 3.36486
Ġdisease 3.9392781
Ġrec 0.78331435
urrence 0.009147591
Ġand 0.5352648
Ġimproving 1.1497878
Ġoverall 1.8856705
Ġsurvival 0.07162493
Ġrates 0.61033815
Ġpost 7.0523653
- 0.23599422
sur 0.9791673
gery 0.00041852458
. 0.15892692
ĠThese 2.430196
Ġtherapies 1.2818538
Ġare 1.4952234
Ġoften 2.626685
Ġtailored 6.1635222
Ġto 0.22472094
Ġthe 0.72916436
Ġspecific 1.8246266
Ġmolecular 4.075795
Ġcharacteristics 1.1229423
Ġof 0.077114865
Ġmelan 3.4882185
oma 0.09471207
, 1.4352447
Ġensuring 5.19364
Ġa 2.6546264
Ġpatient 5.3938956
- 0.5648115
centered 3.181292
Ġapproach 0.5668004
. 1.4625863
Ċ 0.66158646
Impl 7.480869
ications 0.010483267
Ġfor 0.6327576
ĠPatients 0.37704563
Ġat 9.028688
ĠDifferent 0.17157418
ĠSt 0.036696848
ages 0.0009055181
: 1.8033854
Ċ 0.043203607
For 3.9016263
Ġpatients 0.486759
Ġwith 0.69821
Ġearly 1.773725
- 1.5509998
stage 0.012771606
Ġmelan 0.2982597
oma 0.02507804
, 0.33192605
Ġimmune 1.9438818
Ġcheckpoint 0.015011086
Ġinhibitors 0.073491566
Ġhave 0.9868933
Ġshown 1.4785264
Ġpromising 1.8151498
Ġoutcomes 3.3588898
Ġfor 3.5653367
Ġreducing 3.635538
Ġthe 1.5137142
Ġrisk 0.43986925
Ġof 0.007414681
Ġrec 1.1051241
urrence 0.0041321875
. 1.5547475
ĠStudies 4.2197227
Ġhave 0.2601766
Ġshown 0.5991061
Ġthat 0.2164009
Ġpatients 2.2537446
Ġwith 1.5463796
ĠStage 3.7501879
ĠIII 1.7433047
Ġmelan 1.931813
oma 0.010088458
Ġwho 0.8015385
Ġreceive 2.003491
Ġadj 1.9210128
u 0.0015908738
vant 1.9741461e-05
Ġtherapy 0.74278283
Ġwith 3.656909
Ġimmune 0.8164018
Ġcheckpoint 0.009615386
Ġinhibitors 0.06541536
Ġexperienced 6.2102094
Ġsignificantly 2.2310684
Ġbetter 3.3511205
Ġrec 3.4001226
urrence 0.00029676838
- 0.05950918
free 0.0014514871
Ġsurvival 0.19535519
Ġcompared 2.241489
Ġto 0.1012684
Ġtraditional 6.293467
Ġtreatments 3.3021502
. 0.7924325
ĠThis 2.8042805
Ġimplies 5.054045
Ġthat 0.04112594
Ġthese 2.297012
Ġtherapies 2.2893815
Ġcan 1.5326185
Ġpotentially 2.4888628
Ġconvert 6.861161
Ġa 1.6461359
Ġdeadly 4.3400774
Ġdisease 1.7984276
Ġinto 0.26414528
Ġa 0.098685175
Ġmanageable 0.602222
Ġcondition 1.2746998
Ġin 3.323866
Ġthe 1.3883111
Ġlong 2.460154
Ġterm 1.0220559
. 0.12809375
Ċ 0.42645517
In 2.3835242
Ġpatients 1.5925112
Ġwith 0.12444303
Ġadvanced 0.8924057
- 1.1164621
stage 0.0085351905
Ġmelan 0.15984972
oma 0.005838161
, 0.08038143
Ġimmune 1.1731232
Ġcheckpoint 0.0055702603
Ġinhibitors 0.042368736
Ġhave 0.46407938
Ġprovided 4.6962285
Ġpreviously 6.822482
Ġunseen 3.3022633
Ġlevels 2.294803
Ġof 0.0007167771
Ġcontrol 2.3241193
Ġover 1.1520579
Ġthe 0.70187557
Ġdisease 0.39162996
. 0.31268087
ĠThe 3.0714447
Ġuse 4.314853
Ġof 0.0012049318
Ġp 3.4729264
emb 0.0010830789
rol 0.0027094996
iz 0.00063870015
um 0.0014957781
ab 3.357061e-05
Ġhas 2.023567
Ġyielded 4.3866525
Ġremarkable 2.2925754
Ġresults 0.641029
, 1.4221199
Ġwith 0.51383847
Ġstudies 4.7011538
Ġfinding 4.1297607
Ġthat 0.5262437
Ġpatients 2.52214
Ġachieved 4.2473283
Ġhigher 4.867675
Ġobjective 4.495098
Ġresponse 0.052437983
Ġrates 0.06973725
Ġand 0.848322
Ġlonger 0.5481285
Ġprogression 1.1510607
- 0.036352865
free 0.0013159948
Ġsurvival 0.0930137
Ġcompared 1.0770476
Ġto 0.05653796
Ġconventional 3.8667703
Ġchemotherapy 1.3246909
. 0.2546548
ĠThis 2.0282986
Ġoffers 5.8767877
Ġrenewed 5.646701
Ġhope 0.040721145
Ġand 3.5796616
Ġprolonged 4.902934
Ġsurvival 0.15039201
Ġfor 0.5597817
Ġindividuals 5.685881
Ġfacing 4.3078575
Ġadvanced 1.7533867
Ġmelan 1.5347102
oma 0.0022388287
. 0.17331068
Ċ 0.23580399
The 2.2044084
ĠCase 1.909293
Ġof 0.04012273
ĠMr 0.018178146
. 0.022245707
ĠB 0.014990274
: 0.14108256
Ċ 0.04908247
To 5.348635
Ġillustrate 0.8291506
Ġthe 0.18292707
Ġimpact 0.78952897
Ġof 0.067891896
Ġimmune 2.755069
Ġcheckpoint 0.0074379807
Ġinhibitors 0.058926284
Ġin 1.9715042
Ġmelan 1.41375
oma 0.00021002105
Ġtreatment 0.31810597
, 0.033660036
Ġwe 0.85913724
Ġcan 3.0577753
Ġexamine 2.3387477
ĠMr 3.9584556
. 0.001154684
ĠB 0.0077683665
's 1.2326757
Ġcase 0.36740002
. 0.32155213
ĠMr 0.5400382
. 0.013585131
ĠB 0.005257855
Ġwas 0.54849094
Ġdiagnosed 1.3821495
Ġwith 0.03999492
Ġmetast 2.3640647
atic 0.0015418039
Ġmelan 0.19939685
oma 0.00026862667
Ġand 2.660884
Ġwas 2.1686563
Ġinitially 1.9922752
Ġresponding 8.407392
Ġpoorly 6.6960616
Ġto 0.008082505
Ġtraditional 2.675075
Ġtreatments 1.6800473
. 0.3095889
ĠHowever 1.6708014
, 0.0044189775
Ġupon 2.6356912
Ġstarting 4.032662
Ġp 0.9050886
emb 0.0008410892
rol 0.00189372
iz 0.00046110176
um 0.0007759487
ab 3.762558e-05
Ġtherapy 2.7081137
, 0.107122615
Ġhis 1.1630136
Ġtumor 1.4046861
Ġregress 6.975218
ions 0.002753369
Ġwere 1.0779542
Ġobserved 1.875986
, 2.4757578
Ġleading 2.8991828
Ġto 0.051877715
Ġa 1.1012942
Ġdurable 3.7080576
Ġresponse 0.2927078
Ġwith 3.002692
Ġno 1.4731336
Ġdisease 3.3547392
Ġprogression 0.3198446
. 1.9291489
Ċ 1.4740733
This 3.8523126
Ġcase 0.73538125
Ġexempl 2.9849777
ifies 0.008657112
Ġthe 0.3039279
Ġpotential 2.0257158
Ġof 0.23786634
Ġimmune 0.3153632
Ġcheckpoint 0.004670878
Ġinhibitors 0.041101348
Ġin 0.62491924
Ġachieving 1.0883924
Ġlong 0.77239376
- 0.022241501
term 0.07352845
Ġremission 1.3905529
Ġfor 2.107987
Ġpatients 0.7487766
Ġwith 0.47233772
Ġadvanced 0.7204996
Ġmelan 0.8938681
oma 0.0011227585
. 0.14343593
ĠMr 2.6564736
. 0.0014239677
ĠB 0.0053672744
's 0.66144776
Ġexperience 3.8300302
Ġhighlights 1.6072222
Ġhow 1.8756841
Ġtargeted 5.0946546
Ġtherapies 1.1212721
Ġcan 0.56098044
Ġeffectively 3.5373285
Ġhalt 4.511246
Ġdisease 1.073617
Ġprogression 0.015966643
, 1.3072746
Ġextending 4.2165065
Ġsurvival 1.7591387
Ġand 1.2730191
Ġimproving 1.057095
Ġthe 1.3553033
Ġquality 0.22330266
Ġof 0.0023862135
Ġlife 0.040123224
Ġfor 0.33757296
Ġpatients 0.36925408
Ġfacing 2.6918213
Ġa 1.9041317
Ġpreviously 3.8847394
Ġbleak 7.4200597
Ġprog 0.43810716
nosis 0.00066625705
. 0.009981894
Ċ 0.25190994
Conclusion 1.6364758
: 0.051172443
Ċ 0.047385823
The 2.3720703
Ġadvancements 1.943957
Ġin 0.07894204
Ġmelan 0.39368683
oma 2.8445576e-05
Ġtreatment 0.17278387
Ġthrough 5.3958907
Ġimmune 1.0827681
Ġcheckpoint 0.0053682337
Ġinhibitors 0.045699034
Ġand 0.12516409
Ġadj 0.15953058
u 0.023927368
vant 5.145473e-05
Ġtherapies 0.07278708
Ġhave 0.31741098
Ġsignificantly 3.1932783
Ġtransformed 5.6519217
Ġthe 0.30230153
Ġprog 3.0983772
nosis 0.023008725
Ġand 2.342916
Ġquality 1.9568369
Ġof 0.0032132228
Ġlife 0.012240482
Ġfor 0.23462887
Ġpatients 0.22372445
Ġat 2.0383205
Ġdifferent 0.25389618
Ġstages 0.01809463
. 2.1014318
ĠThrough 3.1631594
Ġextensive 6.7321486
Ġresearch 0.25941306
Ġand 0.75175923
Ġevidence 5.8608165
, 1.9821812
Ġit 3.8181884
Ġis 0.60602677
Ġevident 1.5184196
Ġthat 0.020817319
Ġthese 0.82083714
Ġtreatments 1.6183863
Ġoffer 3.0890234
Ġthe 3.1288528
Ġpotential 0.75895435
Ġfor 1.2948519
Ġlong 0.84739375
- 0.01292212
term 0.052266203
Ġremission 0.98747873
, 2.1792212
Ġparticularly 4.7942452
Ġwhen 4.859877
Ġcombined 1.7873977
Ġwith 0.1175986
Ġpersonalized 5.301984
Ġadj 5.1436887
u 0.015401001
vant 1.5925843e-05
Ġtherapies 0.30243808
. 0.1902831
ĠAs 3.0418181
Ġdemonstrated 6.100164
Ġby 0.6772672
ĠMr 0.47859052
. 0.0004223411
ĠB 0.0032186643
's 0.33069152
Ġcase 0.12028253
, 0.018953683
Ġthese 1.2339206
Ġadvancements 3.5505726
Ġbring 6.2895412
Ġhope 1.0323677
Ġfor 1.1721317
Ġpatients 0.8844173
Ġfacing 1.0709497
Ġadvanced 0.5031064
Ġmelan 0.6012152
oma 0.0006752024
, 0.89808565
Ġpromising 5.4751835
Ġincreased 5.0040936
Ġsurvival 0.22065665
Ġrates 0.53841805
Ġand 0.31219435
Ġimproved 1.6211001
Ġoverall 3.6330543
Ġoutcomes 2.3818355
. 0.22065678
ĠContinued 10.969655
Ġresearch 0.35108224
Ġand 1.5083816
Ġinnovation 3.2558274
Ġin 1.0328325
Ġthis 1.4451914
Ġfield 0.20218755
Ġhold 3.9670444
Ġpromise 2.7119067
Ġfor 0.20393255
Ġfurther 2.5477982
Ġadvancements 2.8093467
, 2.8010762
Ġoffering 3.3342474
Ġhope 1.7500145
Ġto 1.5814301
Ġcountless 4.9439845
Ġindividuals 1.0216683
Ġbattling 3.5721157
Ġthis 0.3757836
Ġaggressive 3.1165273
Ġform 0.8317363
Ġof 0.00031691935
Ġskin 0.9956383
Ġcancer 0.0006135903
. 0.014410021
